RxDoctor Payments Data

William Spence, MD

Family Medicine · St Maries, IDNPI 1255351458

Payments from drug & device makers

$411in general payments, 2019–2025

Across 24 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$93
  • Sanofi-aventis U.S. LLC$87
  • Novartis$65
  • Novo Nordisk$57
  • Pfizer$25
  • Dexcom, Inc.$19
  • plus $66 from 4 others

What the payments were for

  • Food & beverage$411100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$411 in reported general payments places this provider in the 55th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$65,786
Medicare patients
108
Services billed
659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin112$115,426
EliquisApixaban65$77,304
OzempicSemaglutide57$65,209
PercocetOxycodone Hcl/Acetaminophen13$59,295
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$22,821
Invega SustennaPaliperidone Palmitate12$22,653
Tresiba Flextouch U-200Insulin Degludec15$16,929
XareltoRivaroxaban11$15,082
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog33$15,051
Breo ElliptaFluticasone/Vilanterol24$12,153
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$10,256
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$9,054
MyrbetriqMirabegron12$8,981
LinzessLinaclotide12$6,768
Combivent RespimatIpratropium/Albuterol Sulfate13$6,533

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$25$77,30465 claims
Novo NordiskOzempic$57$65,20957 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$15$44,02860 claims
Astellas Pharma US IncMyrbetriq$93$8,98112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 803 family medicine providers in Idaho.

Other family medicine in St Maries

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →